Research ArticleArticle
Dehydrocrenatidine Is a Novel Janus Kinase Inhibitor
Jing Zhang, Ning Zhu, Yuping Du, Qifeng Bai, Xing Chen, Jing Nan, Xiaodong Qin, Xinxin Zhang, Jianwen Hou, Qin Wang and Jinbo Yang
Molecular Pharmacology April 2015, 87 (4) 572-581; DOI: https://doi.org/10.1124/mol.114.095208
Jing Zhang
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Ning Zhu
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Yuping Du
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Qifeng Bai
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Xing Chen
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Jing Nan
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Xiaodong Qin
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Xinxin Zhang
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Jianwen Hou
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Qin Wang
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China
Jinbo Yang
Schools of Life Sciences and Basic Medical Sciences, Lanzhou University, Lanzhou, China

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Dehydrocrenatidine Is a Novel JAK Inhibitor
Jing Zhang, Ning Zhu, Yuping Du, Qifeng Bai, Xing Chen, Jing Nan, Xiaodong Qin, Xinxin Zhang, Jianwen Hou, Qin Wang and Jinbo Yang
Molecular Pharmacology April 1, 2015, 87 (4) 572-581; DOI: https://doi.org/10.1124/mol.114.095208